SLN

Silence Therapeutics PLC Sponsored ADR

SLN·82686Q101·US·ADR·Healthcare - Biotechnology-13D/G

SLN (Silence Therapeutics PLC Sponsored ADR) is held by 38 institutional investors as of Q2 2026. Largest holders: CITADEL ADVISORS LLC ($14.6M), MILLENNIUM MANAGEMENT LLC ($10M), BALYASNY ASSET MANAGEMENT L.P. ($6.7M). Net institutional sentiment: Bullish.

38
Holders
(1 Elite)
$73.9M
Total Value
69% (35)
Consensus
24 buying - 11 selling
13F: Insider & Congress: Updated regularly
SLN

Smart Money Verdict

View all
Loading verdict
Held by 38 funds
1 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders none · Activists Aug 13, 2026 · Congress none

ActivistRDRaymond Debbane7.0%Aug 13, 2026

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
1.3M(+7.7%)$14.6M0.0%+121.02%
30
Decreased
909,279(-15.3%)$10M0.0%+60.52%
0
New
610,980$6.7M0.0%+23.22%
38
Increased
403,172(+515.7%)$4.4M0.0%+24.05%
43
New
370,052$4.1M0.0%+23.22%
37
Increased
369,151(+265.8%)$4.1M0.0%+41.47%
43
New
269,348$3M0.0%+23.22%
36
Decreased
243,152(-1.5%)$2.7M0.0%+60.14%
0
Increased
219,917(+7.4%)$2.4M0.0%+111.31%
19
Decreased
201,734(-0.6%)$2.2M0.0%+165.12%
0
Increased
184,519(+60.1%)$2M0.0%+75.69%
37
New
177,000$1.9M0.0%+23.22%
36
Increased
163,945(+56.8%)$1.8M0.0%+75.90%
37
New
162,476$1.8M0.0%+23.22%
36
Increased
158,950(+7.6%)$1.7M0.0%+122.93%
28
Increased
155,929(+196.9%)$1.7M0.0%+47.23%
41
Increased
121,004(+646.8%)$1.3M0.0%+11.87%
41
Unchanged
122,834$1.3M0.0%-10.25%
0
New
118,129$1.3M0.0%+23.22%
35
Increased
115,918(+29.6%)$1.3M0.0%+96.83%
32

Showing 1-20 of 40

1 / 2
SLNSLNSilence Therapeutics PLC Sponsored ADR

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used